the-infoshop.com - The vertical markets research portal
View CartView Cart
Global Information, Inc.
US: +1-860-674-8796
EU: +32-2-535-7543
SG: +65-6223-2436
  Home | Catalog | E-mail Alert | Custom Research | About The Infoshop | Contact Us | Site Map |

* View All Categories

Biotechnology Market Research

Clinical Stage Partnering Agreements in Biopharma
<< Previous Page:   11   12   13   14   15   16   17   18   19   20   21   22   Next >>

Reports

Neurogenomics and Neurotherapeutic Strategies: New Directions in Platforms, Targets, and Therapeutic Approaches
Published : 2005/03
CNS disorders affect a vast patient population and represent a huge area of unmet therapeutic need. In the United States alone, Alzheimerfs disease (AD), Parkinsonfs disease (PD), and amyotrophic lateral sclerosis (ALS) afflict more than 6.5 million peo ...

Post-Genomic Biomarkers: Revolutionizing Drug Development and Diagnostics 2nd Edition
Published : 2005/03
The first edition of D&MD Publications' report, covering post-genomic biomarkers, was published in September 2003. ...

Protein Drug Delivery: Penetrating a Growth Market
Published : 2005/03
The protein therapeutic market is forecast to grow rapidly at a CAGR of 10.5% from 2003 to 2010, to almost double in value. ...

Strategies for Innovation in Pharmaceutical R&D: Enhancing R&D Through Biotech Alliances and CRO Outsourcing
Published : 2005/03
This new report has been written to provide members of pharmaceutical, biotechnology and clinical research sectors an analytically-based overview of the mechanisms of the partnering process, and the key issues and trends affecting these arrangements. ...

The Biogenerics Market Outlook: An Analysis of Market Dynamics, Growth Drivers and Leading Players
Published : 2005/03
Branded biologic medicines generated an estimated $32bn of sales for the biotechnology and pharmaceutical industries and represented the fastest growing group of medicines; while continued high demand, high prices, and applicability in previously untreata ...

The Forensic Business: Highlighting Technologies, Opportunities
Published : 2005/03
Forensic science recently has garnered considerable publicity from highprofile court cases involving DNA testing and popular television shows. ...

Therapeutic Vaccines: Targets, Technologies and Markets
Published : 2005/03
This BCC study provides a comprehensive analysis of available and emerging therapeutic vaccines. It details a range of information, from product analyses through industry trends, and quantifies and qualifies what is expected to become an explosive market ...

Beyond the Blockbuster Drug: Strategies for nichebuster drugs, targeted therapies and personalized medicine
Published : 2005/02
The blockbuster model now delivers just 5% return on investment and only one in six new drug prospects will deliver returns above their cost of capital, as a result competitive pressures and falling R&D productivity will instigate a new pharmaceutical mod ...

Diabetes Monitoring Products & Therapy to 2008
Published : 2005/02
This new Freedonia industry study, Diabetes Monitoring & Therapy provides historical US demand data (1993, 1998, 2003) and forecasts to 2008 and 2013 for diabetes products by type and market. ...

DNA/RNA Therapies: Translating the Genome into a $1.2bn Market by 2010
Published : 2005/02
The DNA/RNA market is in its infancy with no significant products launched across the seven major markets. ...

European Markets for Reconstructive Implants 2005
Published : 2005/02
As procedure volumes continue to rise driven by favorable demographics, unit sales for reconstructive implants will increase appreciably from 2005 to 2009. ...

Human Reproductive Technologies: Products, Markets and Manufacturers
Published : 2005/02
In each of the three major areas of infertility, contraception and sexual dysfunction, there is increasing interest and advancements. ...

Molecular Diagnostics State of the Industry
Published : 2005/02
The impact of SNPs and other molecular diagnostic markers is now being felt--this will grow as more molecular markers are validated and launched for their diagnostic and prognostic value. ...

Prions: A Primer for the Biopharmaceutical Industry
Published : 2005/02
Transmissible spongiform encephalopathy (TSE) agents, or prions as they are commonly referred to, are a significant concern to the biologicals and biotechnology industries. ...

Solving Drug Discovery with Metabolomics and Metabonomics: New Aspects of the "Omic" Revolution
Published : 2005/02
This Report will analyze the biochemical nature of metabolomics, the technologies behind metabolomics, metabonomics related approaches, and the appropriate market potentials. ...

Spectrum Quarterly Deal Review--Fourth Quarter 2004
Published : 2005/02
The life sciences industry closed 2004 with a robust fourth quarter. The industry demonstrated its vitality by attracting more than $10 billion in financing, owing mostly to a thoroughly rebounded debt financing environment. ...

Therapeutic Proteins
Published : 2005/02
Proteins that are engineered in the laboratory for pharmaceutical use are known as therapeutic proteins. ...

U.S. ADME/Tox in Drug Development Markets
Published : 2005/02
This research service provides an overview of the U.S. ADME/Tox markets. The study has been divided into in vitro, in vivo, and in silico ADME/Tox segments. The research service provides industry challenges to both vendors and consumers as well as offers ...

Vascular Targeting Agents: Emerging Competitors
Published : 2005/02
In this issue of Cancer Highlights, BioSeeker Group analyzes the progress made for vascular targeting agents (VTA). ...

Worldwide Market for Cancer Therapeutics
Published : 2005/02
The study focuses on current and emerging markets, products in development, and trends affecting the cancer treatment market. ...

Improving Sales Rep Performance: A Global Analysis
Published : 2005/01
Sales reps are a vital part of a life science supplier's success because they provide a direct link to scientists. ...

In Vitro Diagnostics in the Global Market Report 2005
Published : 2005/01
This year, the world market in 2005 for In Vitro Diagnostics will be in excess of $20bn - but what will it be next year, or in 2009 ...

Nucleic Acid-Based Therapeutics: World Markets, Developments, and Applications
Published : 2005/01
This report focuses on the application of nucleic acid-based therapeutics to the prevention and treatment of various diseases and disorders ...

Opportunities for European Pharmaceutical and Biotechnology Companies in Indian and Chinese Markets
Published : 2005/01
This research service offers an exhaustive strategic analysis of the opportunities for European pharmaceutical and biotechnology companies in Indian and Chinese markets. ...

Proteases as Drug Targets: Technologies and Opportunities for Drug Discovery
Published : 2005/01
Proteases are a superfamily of enzymes with important roles in the regulation of cellular protein activity. There are at least 475 known and putative proteases and 103 homologs to known proteases in humans, and it is estimated that up to 1,200 human genes ...

Protein-Protein Interactions as Drug Targets: Focusing on Cell Circuitry
Published : 2005/01
The area of protein-protein interaction has been growing at a tremendous rate. The market is expected to reach over $50 billion by year 2010. ...

RNAi: Broad Application, Expansive Opportunity, 2nd Edition
Published : 2005/01
The drug discovery market based on RNAi is projected to be $650 million in 2005 and $1 billion by 2010. Don't miss out on your share of this growing market! ...

Strategic Analysis of the ADME/TOX Technologies Market in Europe
Published : 2005/01
This research service covers the European ADME/Tox technologies market. It examines the existing competitive structure and evaluates the business potential in major markets, taking into account market drivers and industry dynamics. The study also looks at ...

Strategic Analysis of the European In Vitro Cancer Diagnostics Market
Published : 2005/01
With cancer-related deaths in Europe touching one million, there has been a substantial rise in the consumption of resources for diagnosis, treatment and care. ...

Beyond Chemotherapy Battling Cancer with Biotechnology
Published : 2004/12
Global revenues from biotech-enabled cancer therapies are expected to rise at an AAGR (average annual growth rate) of 14.5% from $15 billion in 2003 to more than $29 billion in 2008. ...

Biogenerics: Challenges and Promise
Published : 2004/12
This report primarily focuses on how the generics industry will be shaped by the global healthcare market and regulatory developments over the next five years. The international biogenerics market faces a multitude of challenges. ...

Brand Perceptions of Life Science Instrumentation Suppliers
Published : 2004/12
Developments in instrumentation (i.e., scientific equipment with a purchase price of at least $25,000 and a service life of two years or more) have advanced the progress of research in every branch of science. ...

Drug Discovery--European Advances in Genomics and Proteomics
Published : 2004/12
The European Union (EU) has become a popular hub for advanced research into genomics and proteomics. ...

Emerging Vaccines and Therapies--Analysis of Technological Trends
Published : 2004/12
Recent advances in immunology and vaccinology have increased the hope that new vaccines will target other diseases such as cancers, immune system disorders, allergies, autoimmune diseases and even cocaine and nicotine addictions. ...

High-Content Screening and Implications for IT
Published : 2004/12
This Life Science Insights study focuses on the impact of HCS technologies on the life science industry, ...

KEY DIAGNOSTIC TESTING MARKETS
Published : 2004/12
This TriMark Publications report reviews the high-growth market segments for clinical laboratory testing equipment and supplies in the clinical hospital market, using screening reagents and instruments for analysis of individual components in blood, serum ...

Market Snapshot: Lab-on-a-Chip
Published : 2004/12
This report takes a look at the continually evolving lab-on-a-chip sector, including the companies developing these devices and the markets they're pursuing. Forecasts of both unit shipments and revenues are provided through 2008 ...

Markets for Advanced Wound Care Technologies
Published : 2004/12
The total U.S. market for advanced wound care was estimated at more than $1.7 billion in 2003 and is expected to rise at an AAGR (average annual growth rate) of 10.2% to $2.8 billion. ...

Security Technology--Biological and Chemical Detection
Published : 2004/12
The study provides an insight into the varied segments -portable and stationary defense systems, defense systems in transportation sectors, facilities management systems such as sensing equipment, and public safety equipment such as hand-held detectors ...

Strategic Analysis of the Opportunities for the Pharmaceutical and Biotechnology Industry in the 'New' EU Countries
Published : 2004/12
The addition of new countries to the European Union (EU) has changed the dynamics within its healthcare industry, which is now the second largest industry in the world following North America. ...

Strategic Analysis of the World Plant Molecular Farming Market
Published : 2004/12
The demand for biopharmaceuticals is increasing, but little progress is being made to reduce production costs or increase manufacturing capacity. ...

Toxicogenomics and Predictive Toxicology: Market and Business Outlook
Published : 2004/12
Toxicogenomics and Predictive Toxicology: Market and Business Outlook addresses the significant need and potential for predictive toxicology in drug development. ...

US Markets for Drug Delivery
Published : 2004/12
The US market for drug delivery devices andtechnology was one of the most profi table andquickly growing markets in the US medical devicesand healthcare fi elds. ...

Advances in RNAi--A Global Technology Assessment
Published : 2004/11
This Frost & Sullivan research analyzes emerging technologies and applications in RNAi design and delivery. ...

Cell Culture Products: European Customer Market Survey
Published : 2004/11
Information was collected through both online and tele-surveys in the UK , French and German markets. In total 1248 responses were obtained from both Technical and Economic Buyers. ...

Membrane Technology for Biopharmaceuticals
Published : 2004/11
This BCC technical market report provides an in-depth analysis of the market for membrane technology across a range of life science/biotech applications including gene and protein analysis. ...

Microarrays: Technologies, Applications, Markets
Published : 2004/11
Microarrays: Technologies, Applications, Markets evaluates the competitive picture, growth trends, and deal-making activities in this dynamic and rapidly-growing market. ...

Molecular Biology Products: European Customer Market Survey
Published : 2004/11
Information was collected from 391 interviews with both Technical and Economic Buyers of Molecular Biology products in the UK , French and German markets. ...

Structure-Guided Drug Design Rediscovering the Importance of Drug Structure for Drug Discovery
Published : 2004/11
This Report describes the many advances including crystallography and informatics that are behind these successes. The Report also discusses the impact these advances in structure-based drug design are likely to have on the economics of drug discovery. ...

Biochips to 2008
Published : 2004/10
This study analyzes the US market for biochip products and services. Products examined include DNA, laboratory and protein chips (microarrays); production, detection, and sample preparation and hybridization instruments; reagents and other consumables; an ...


<< Previous Page:   11   12   13   14   15   16   17   18   19   20   21   22   Next >>

Available 24 Hours a Day
US: 1-860-674-8796 EU: 32-2-535-7543 SG: 65-6223-2436
The vertical markets research portal
© 2008, the-infoshop.com by Global Information, Inc. All rights reserved.